Switching Between Infliximab Originator and Biosimilar in Paediatric Patients with Inflammatory Bowel Disease. Preliminary Observations by Sieczkowska, J., Jarzębicka, D., Banaszkiewicz, A., Plocek, A., Gawronska, A., Toporowska-Kowalska, E., Oracz, G., Meglicka, M., Kierkus, J.

Get full text

P369 Dual Biologic in Moderate to Severe Pediatric Inflammatory Bowel Disease: A Case Series by Wlazło, M, Jarzębicka, D, Meglicka, M, Kierkuś, J

Get full text

P216 Effect of the Crohn’s disease exclusion diet (CDED) on the fecal calprotectin level in children with active Crohn’s disease by Matuszczyk, M, Meglicka, M, Wiernicka, A, Jarzebicka, D, Osiecki, M, Kotkowicz-Szczur, M, Kierkus, J

Get full text

P504 Differences between paediatric and adult inflammatory bowel disease presentation – analysis based on the data from multicenter, prospective cohort observational study assessin... by Sieczkowska-Golub, J., Jarzebicka, D., Borys-Iwanicka, A., Korlatowicz-Bilar, A., Szaflarska-Popławska, A., Grzybowska-Chlebowczyk, U., Łazowska-Przeorek, I., Daniluk, U., Korczowski, B., Sordyl, B., Szczepanik, M., Landowski, P., Plocek, A., Bąk-Drabik, K., Zagorowicz, E., Kierkus, J.

Get full text

P510 Assessment of study group – patients with inflammatory bowel disease, treated with monoclonal anti-TNF alpha: a multicenter, prospective cohort observational study, Satimos –... by Jarzebicka, D., Sieczkowska, J., Borys-Iwanicka, A., Korlatowicz-Bilar, A., Szaflarska-Popławska, A., Grzybowska-Chlebowczyk, U., Łazowska-Przeorek, I., Daniluk, U., Korczowski, B., Sordyl, B., Szczepanik, M., Landowski, P., Plocek, A., Bąk-Drabik, K., Zagόrowicz, E., Kierkus, J.

Get full text